Application 212062
- Type
- ANDA
- Sponsor
- TORRENT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 40MG | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-581 | TADALAFIL | TADALAFIL | Torrent Pharmaceuticals Limited | ANDA | Current |